SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CALO', Girolamo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.317
AS - Asia 16.023
EU - Europa 8.818
SA - Sud America 2.374
Continente sconosciuto - Info sul continente non disponibili 518
AF - Africa 341
OC - Oceania 31
Totale 64.422
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 35.537
SG - Singapore 6.034
CN - Cina 3.947
DE - Germania 1.810
BR - Brasile 1.805
VN - Vietnam 1.779
IT - Italia 1.558
UA - Ucraina 1.470
HK - Hong Kong 1.238
GB - Regno Unito 981
TR - Turchia 957
FI - Finlandia 768
BD - Bangladesh 547
FR - Francia 542
SE - Svezia 436
CA - Canada 418
RU - Federazione Russa 416
JP - Giappone 357
IN - India 313
MX - Messico 219
PL - Polonia 218
AR - Argentina 198
ID - Indonesia 183
NL - Olanda 124
IQ - Iraq 122
ZA - Sudafrica 121
BE - Belgio 91
EC - Ecuador 91
ES - Italia 82
PK - Pakistan 82
CO - Colombia 72
LT - Lituania 58
MA - Marocco 57
VE - Venezuela 56
MY - Malesia 54
SA - Arabia Saudita 54
IE - Irlanda 52
PH - Filippine 52
CL - Cile 46
UZ - Uzbekistan 46
CZ - Repubblica Ceca 38
PY - Paraguay 38
TN - Tunisia 37
AT - Austria 36
AE - Emirati Arabi Uniti 33
JM - Giamaica 32
NP - Nepal 28
EG - Egitto 26
KE - Kenya 25
UY - Uruguay 24
JO - Giordania 23
PE - Perù 22
AU - Australia 20
AZ - Azerbaigian 20
IR - Iran 20
DZ - Algeria 18
AL - Albania 17
CH - Svizzera 17
HN - Honduras 17
TH - Thailandia 17
IL - Israele 16
KR - Corea 16
BO - Bolivia 13
CR - Costa Rica 13
TT - Trinidad e Tobago 13
DO - Repubblica Dominicana 12
RO - Romania 12
LB - Libano 11
BG - Bulgaria 10
SN - Senegal 10
SV - El Salvador 10
ET - Etiopia 9
MD - Moldavia 9
NZ - Nuova Zelanda 9
PA - Panama 9
BH - Bahrain 8
GR - Grecia 8
GT - Guatemala 8
KZ - Kazakistan 8
PT - Portogallo 8
TW - Taiwan 8
DK - Danimarca 7
HR - Croazia 7
NG - Nigeria 7
NI - Nicaragua 7
RS - Serbia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
CY - Cipro 6
GY - Guiana 6
NO - Norvegia 6
AM - Armenia 5
EU - Europa 5
GD - Grenada 5
LV - Lettonia 5
OM - Oman 5
PS - Palestinian Territory 5
KG - Kirghizistan 4
KH - Cambogia 4
LK - Sri Lanka 4
LU - Lussemburgo 4
Totale 63.824
Salva come PNG Salva come JPEG
Città #
Ashburn 4.127
Singapore 3.817
Fairfield 3.307
Woodbridge 2.892
San Jose 2.274
Houston 2.009
Jacksonville 1.598
Ann Arbor 1.518
Chandler 1.393
Seattle 1.370
Santa Clara 1.298
Dallas 1.292
Beijing 1.223
Hong Kong 1.206
Wilmington 1.182
Cambridge 1.156
Council Bluffs 782
Munich 617
Los Angeles 596
New York 595
Ho Chi Minh City 579
Izmir 548
Nanjing 457
Hanoi 373
Princeton 356
Tokyo 341
Ferrara 335
Helsinki 318
Lauterbourg 308
San Diego 290
Milan 281
Boardman 265
Shanghai 212
São Paulo 202
Warsaw 195
London 153
Nanchang 139
Orem 138
Brooklyn 133
Shenyang 129
Dearborn 128
Turku 128
Mexico City 122
Toronto 122
Montreal 121
Atlanta 116
Denver 114
Chicago 110
Falkenstein 109
Tianjin 105
Buffalo 103
Hefei 103
Frankfurt am Main 100
Jakarta 99
Phoenix 99
Da Nang 94
The Dalles 93
Falls Church 92
San Francisco 87
Brussels 85
Hebei 81
San Mateo 81
Moscow 79
Norwalk 78
Jiaxing 75
Bremen 74
Johannesburg 74
Changsha 70
Chennai 69
Boston 68
Rio de Janeiro 65
Mountain View 64
Redwood City 64
Haiphong 62
Jinan 59
Stockholm 59
Bologna 57
Philadelphia 56
Washington 54
Guangzhou 53
Manchester 52
Rome 51
Dublin 50
Addison 48
Auburn Hills 48
Dhaka 47
Amsterdam 45
Dong Ket 45
Baghdad 44
Kunming 44
Zhengzhou 44
Mumbai 43
Poplar 42
Tashkent 42
Belo Horizonte 38
Ankara 36
Hải Dương 34
Columbus 33
Lahore 33
Naples 32
Totale 44.327
Salva come PNG Salva come JPEG
Nome #
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 1.253
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 999
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 401
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 387
Chimeric G proteins in fluorimetric calcium assays: Experience with opioid receptors 347
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 343
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 326
In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl 316
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 305
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 300
Effects of vasoactive agents in healthy and diseased human saphenous veins 283
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 283
A new selective antagonist of the nociceptin receptor 282
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 277
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 276
Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor 274
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 273
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 272
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 268
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 268
A new ligand for the urotensin II receptor 261
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 260
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 257
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 254
The effect of guanethidine and local anaesthetics on the electrically stimulated mouse vas deferens 252
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 250
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 249
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 248
Actual concept of "probiotics": is it more functional to science or business? 248
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 248
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 247
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 246
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 245
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 244
AMPA receptor activation regulates the glutamate metabotropic receptor stimulated phosphatidylinositol turnover in human cerebral cortex slices 244
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 243
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 243
A simple method for electrical field stimulation of cultured granule cells 242
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 241
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 241
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 240
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 239
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 237
[Nphe(1),Arg(14),Lys(15)]N/OFQ-NH2 is a competitive antagonist of NOP receptors in the periaqueductal gray 235
Structural Bacterial Molecules as Potential Candidates for an Evolution of the Classical Concept of Probiotics 235
Cardiovascular effects of nociceptin in unanesthetized mice 234
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 234
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 234
Modulation of the NOP receptor signaling affects resilience to acute stress 234
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 234
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 234
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 233
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 233
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 232
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 232
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 230
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 226
Dmt-Tic-NH-CH2-Bid (UFP-502), a potent DOP receptor agonist: In vitro and in vivo studies 226
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 226
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation 225
Neuropeptide S receptor ligands: a patent review (2005-2016) 225
[Nphe(1)]-Nociceptin (1-13)-NH2, a nociceptin receptor antagonist, reverses nociceptin-induced spatial memory impairments in the Morris water maze task in rats 224
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 224
Pharmacological characterisation of novel kinin B2 receptor ligands 224
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 224
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 223
Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems 223
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 223
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 223
Pharmacological characterization of tachykinin tetrabranched derivatives 222
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 221
Electrocardiographic alterations as a result of acute intoxication with fluvoxamine and pipamperone 221
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration 220
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 220
B1 and B2 kinin receptors in various species 218
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 218
Emergency admissions of opioid drug-abusers for overdose. A chronobiological study of enhanced risk 216
Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction 216
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 215
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 215
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 214
Ring size in cyclic endomorphin-2 analogs modulates receptor binding affinity and selectivity 213
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 213
Sudden death from pulmonary thromboembolism: chronobiological aspects 212
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex 211
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 211
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 211
Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands 209
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 209
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 209
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 208
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 208
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 208
Pharmacological characterization of nociceptin receptor: an in vitro study 208
Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with C alpha,alpha-dialkylated amino acids 207
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 206
null 205
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 205
(2S)-N-2-methoxy-2-phenylethyl-6,7-benzomorphan compound (2S-LP2): Discovery of a biased mu/delta opioid receptor agonist 205
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 205
Totale 25.941
Salva come PNG Salva come JPEG
Categoria #
all - tutte 287.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.088
Totale 292.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.131 0 0 312 217 203 190 217 236 156 302 313 985
2022/20233.455 379 160 114 414 572 485 177 315 470 21 196 152
2023/20241.783 196 229 88 50 99 310 74 142 35 30 53 477
2024/20257.710 184 203 632 256 875 769 271 496 1.226 795 1.075 928
2025/202622.595 2.223 1.107 2.409 2.779 3.039 1.412 2.592 1.114 1.963 2.327 1.002 628
2026/20273.396 1.706 1.130 560 0 0 0 0 0 0 0 0 0
Totale 64.422